The GSEA results suggest that ENTPD1, SERPINA1, and TACSTD2 may be involved in the occurrence and development of PTC by jointly regulating the spliceosome, Parkinson’s disease, and cytokine–cytokine receptor interaction pathways. This evidence concerns the gene ENTPD1 and Parkinson disease.